CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 684 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00551655
NCT00551655N/ACompleted
CompareCT.gov

Impact of Drug Therapy and Co-Morbidities on the Development of Renal Impairment in HIV-Infected Patients

AIDS Arms Inc.·observational·Posted Oct 31, 2007·Updated Nov 6, 2007

In Brief

An observational study for Human Immunodeficiency Viruses and 2 related conditions. Completed, enrolled 684 participants across 1 site.

Detailed Summary

Tenofovir (TDF)-containing regimens may be associated with decreasing renal function in HIV-infected patients concurrently treated with boosted PI's and/or have co-morbid conditions including diabetes mellitus, hypertension, anemia, hepatitis B, and hepatitis C.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHuman Immunodeficiency Viruses, Kidney Failure, HIV Infections
CountriesUnited States
CollaboratorsGlaxoSmithKline

Timeline

N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedOct 31, 2007
Enrollment StartMay 1, 2007
Study CompletionSep 1, 2007
TodayJul 2, 2026
Posted 18.7 years ago